formoterol fumarate has been researched along with procaterol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, JG | 1 |
Beeson, CC; Cameron, RB; Lindsey, CC; Peterson, YK; Schnellmann, RG; Trager, RE; Wills, LP | 1 |
Gmeiner, P; Hübner, H; Stanek, M; Weichert, D | 1 |
3 other study(ies) available for formoterol fumarate and procaterol
Article | Year |
---|---|
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; Propanolamines; Radioligand Assay | 2010 |
β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis.
Topics: Adrenergic beta-2 Receptor Agonists; Aniline Compounds; Cells, Cultured; Humans; Mitochondria; Models, Molecular; Molecular Structure; Phenotype | 2013 |
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2 | 2016 |